Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My alerts
  • My Cart

Main menu

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About AAC
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • AAC Podcast
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My alerts
  • My Cart

Search

  • Advanced search
Antimicrobial Agents and Chemotherapy
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About AAC
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • AAC Podcast
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
Antiviral Agents

Genotypic Analysis of the V3 Region of HIV from Virologic Nonresponders to Maraviroc-Containing Regimens Reveals Distinct Patterns of Failure

Luke C. Swenson, Celia K. S. Chui, Chanson J. Brumme, Dennison Chan, Conan K. Woods, Theresa Mo, Winnie Dong, Doug Chapman, Marilyn Lewis, James F. Demarest, Ian James, Simon Portsmouth, James Goodrich, Jayvant Heera, Hernan Valdez, P. Richard Harrigan
Luke C. Swenson
BC Centre for Excellence in HIV/AIDS, Vancouver, BC, Canadaa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Celia K. S. Chui
BC Centre for Excellence in HIV/AIDS, Vancouver, BC, Canadaa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Chanson J. Brumme
BC Centre for Excellence in HIV/AIDS, Vancouver, BC, Canadaa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dennison Chan
BC Centre for Excellence in HIV/AIDS, Vancouver, BC, Canadaa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Conan K. Woods
BC Centre for Excellence in HIV/AIDS, Vancouver, BC, Canadaa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Theresa Mo
BC Centre for Excellence in HIV/AIDS, Vancouver, BC, Canadaa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Winnie Dong
BC Centre for Excellence in HIV/AIDS, Vancouver, BC, Canadaa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Doug Chapman
Pfizer, Inc., New York, New York, USAb
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marilyn Lewis
Pfizer, Inc., New York, New York, USAb
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
James F. Demarest
ViiV Healthcare, Research Triangle Park, North Carolina, USAd
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ian James
Pfizer, Inc., New York, New York, USAb
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Simon Portsmouth
Pfizer, Inc., New York, New York, USAb
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
James Goodrich
ViiV Healthcare, Research Triangle Park, North Carolina, USAd
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jayvant Heera
Pfizer Global Research and Development, New London, Connecticut, USAc
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hernan Valdez
Pfizer, Inc., New York, New York, USAb
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
P. Richard Harrigan
BC Centre for Excellence in HIV/AIDS, Vancouver, BC, Canadaa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1128/AAC.01534-13
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Information

DOI 
https://doi.org/10.1128/AAC.01534-13
PubMed 
24080655

Published By 
American Society for Microbiology Journals
History 
  • Received July 16, 2013
  • Returned for modification August 27, 2013
  • Accepted September 20, 2013
  • Published online November 12, 2013.

Copyright & Usage 
Copyright © 2013, American Society for Microbiology. All Rights Reserved.

Article Versions

  • Accepted Manuscript version (September 30, 2013).
  • You are viewing the most recent version of this article.

Author Information

  1. Luke C. Swensona,
  2. Celia K. S. Chuia,
  3. Chanson J. Brummea,
  4. Dennison Chana,
  5. Conan K. Woodsa,
  6. Theresa Moa,
  7. Winnie Donga,
  8. Doug Chapmanb,
  9. Marilyn Lewisb,
  10. James F. Demarestd,
  11. Ian Jamesb,
  12. Simon Portsmouthb,
  13. James Goodrichd,
  14. Jayvant Heerac,
  15. Hernan Valdezb and
  16. P. Richard Harrigana
  1. BC Centre for Excellence in HIV/AIDS, Vancouver, BC, Canadaa
  2. Pfizer, Inc., New York, New York, USAb
  3. Pfizer Global Research and Development, New London, Connecticut, USAc
  4. ViiV Healthcare, Research Triangle Park, North Carolina, USAd
  • Address correspondence to P. Richard Harrigan, prharrigan{at}cfenet.ubc.ca.
View Abstract

Article usage

Article usage: September 2013 to January 2021

Rendering graph...
AbstractFullPdf
Sep 20132602
Oct 2013143042
Nov 20133802249
Dec 20132622531
Jan 20141001514
Feb 201451710
Mar 201439915
Apr 20142058
May 201420911
Jun 201443417
Jul 2014172215
Aug 2014201012
Sep 201491114
Oct 20141439
Nov 20141764
Dec 201431426
Jan 201513269
Feb 201515108
Mar 2015201413
Apr 20151239
May 20151237
Jun 201512147
Jul 2015131816
Aug 201533238
Sep 201513229
Oct 201511812
Nov 20158112
Dec 201513610
Jan 20168614
Feb 20161263
Mar 2016231914
Apr 20161159
May 2016625
Jun 201611710
Jul 20161448
Aug 201611010
Sep 2016577
Oct 20161907
Nov 2016986
Dec 2016957
Jan 2017711
Feb 2017914
Mar 20171153
Apr 2017512
May 2017740
Jun 2017706
Jul 2017413
Aug 2017222
Sep 20171146
Oct 20171223
Nov 20171266
Dec 201714533
Jan 2018638
Feb 2018521
Mar 2018913
Apr 2018726
May 2018740
Jun 2018802
Jul 2018545
Aug 2018663
Sep 2018051
Oct 2018283
Nov 2018077
Dec 2018034
Jan 2019185
Feb 20190710
Mar 20191128
Apr 20191109
May 20192817
Jun 2019148
Jul 2019095
Aug 20191713
Sep 20190610
Oct 2019379
Nov 2019054
Dec 2019059
Jan 2020186
Feb 2020378
Mar 2020056
Apr 20200126
May 20200144
Jun 20200169
Jul 2020073
Aug 2020034
Sep 20200124
Oct 202011910
Nov 20203136
Dec 2020384
Jan 2021065
PreviousNext
Back to top
Download PDF
Citation Tools
Genotypic Analysis of the V3 Region of HIV from Virologic Nonresponders to Maraviroc-Containing Regimens Reveals Distinct Patterns of Failure
Luke C. Swenson, Celia K. S. Chui, Chanson J. Brumme, Dennison Chan, Conan K. Woods, Theresa Mo, Winnie Dong, Doug Chapman, Marilyn Lewis, James F. Demarest, Ian James, Simon Portsmouth, James Goodrich, Jayvant Heera, Hernan Valdez, P. Richard Harrigan
Antimicrobial Agents and Chemotherapy Nov 2013, 57 (12) 6122-6130; DOI: 10.1128/AAC.01534-13

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print

Alerts
Sign In to Email Alerts with your Email Address
Email

Thank you for sharing this Antimicrobial Agents and Chemotherapy article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Genotypic Analysis of the V3 Region of HIV from Virologic Nonresponders to Maraviroc-Containing Regimens Reveals Distinct Patterns of Failure
(Your Name) has forwarded a page to you from Antimicrobial Agents and Chemotherapy
(Your Name) thought you would be interested in this article in Antimicrobial Agents and Chemotherapy.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Genotypic Analysis of the V3 Region of HIV from Virologic Nonresponders to Maraviroc-Containing Regimens Reveals Distinct Patterns of Failure
Luke C. Swenson, Celia K. S. Chui, Chanson J. Brumme, Dennison Chan, Conan K. Woods, Theresa Mo, Winnie Dong, Doug Chapman, Marilyn Lewis, James F. Demarest, Ian James, Simon Portsmouth, James Goodrich, Jayvant Heera, Hernan Valdez, P. Richard Harrigan
Antimicrobial Agents and Chemotherapy Nov 2013, 57 (12) 6122-6130; DOI: 10.1128/AAC.01534-13
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
    • ABSTRACT
    • INTRODUCTION
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • FOOTNOTES
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

Cited By...

About

  • About AAC
  • Editor in Chief
  • Editorial Board
  • Policies
  • For Reviewers
  • For the Media
  • For Librarians
  • For Advertisers
  • Alerts
  • AAC Podcast
  • RSS
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • ASM Author Center
  • Submit a Manuscript
  • Article Types
  • Ethics
  • Contact Us

Follow #AACJournal

@ASMicrobiology

       

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

Print ISSN: 0066-4804; Online ISSN: 1098-6596